Pharmaceuticals, Inc. (NASDAQ:TTPH) , a clinical-stage
biopharmaceutical company whose lead product candidate, eravacycline, is
being developed as a broad-spectrum intravenous and oral antibiotic
designed to be effective against multidrug-resistant bacteria, today
announced that Guy
Macdonald, Tetraphase President and Chief Executive Officer , will
present at the Oppenheimer 25 th Annual Healthcare Conference
on Thursday, December 11 at 1:00 p.m. Eastern Time.
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company
focused on delivering innovative therapies to patients with kidney
disease through the biology of hypoxia inducible factor (HIF), today
announced that John P.
Staples (NASDAQ:SPLS), one of the world’s largest internet retailers,
today announced the roll-out of Staples Exchange, a world-class platform
that makes it easy for suppliers to offer products to Staples customers.
By David Weidner, MarketWatch Peer-to-peer loans imperil banks, and cryptocurrencies may finish the job
SAN FRANCISCO (MarketWatch) -- Wall Street's greatest threat isn't from regulation or another meltdown.
By Carla Mozee, MarketWatch
LONDON (MarketWatch) -- European stocks were higher and the euro slipped Thursday, with investors waiting for a European Central Bank news conference that could indicate whether the central bank will ramp up its stimulus efforts.
By Jeff Reeves, MarketWatch From Janet Yellen to black swans, investors should prepare
It is shaping up to be another great year for stocks, with the S&P 500 up about 12% year-to-date in 2014 after a roughly 30% gain in 2013.
Small business owners are the most optimistic they have been in more
than six years, and business owners are feeling the most upbeat about
the year ahead since the start of the Great Recession, according to the
Fargo/Gallup Small Business Index .
By Barbara Kollmeyer, MarketWatch Sears, Dollar General due to report ahead of the bell
LONDON (MarketWatch) -- U.S. stocks were pointing to a flat start for Wall Street on the heels of another record-breaking action, with Thursday's session hinging on a European Central Bank meeting and news conference, as well as on weekly jobless claims data.
STONY BROOK, NY--(Marketwired - December 04, 2014) - Applied DNA Sciences, Inc. (NASDAQ: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that it has signed an agreement for use of its SigNature ®
DNA anti-counterfeiting technology with a government agency.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.